These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37192725)

  • 1. SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells.
    Gori Savellini G; Anichini G; Cusi MG
    Virus Res; 2023 Jul; 332():199134. PubMed ID: 37192725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.
    Kehrer T; Cupic A; Ye C; Yildiz S; Bouhaddou M; Crossland NA; Barrall EA; Cohen P; Tseng A; Çağatay T; Rathnasinghe R; Flores D; Jangra S; Alam F; Mena I; Aslam S; Saqi A; Rutkowska M; Ummadi MR; Pisanelli G; Richardson RB; Veit EC; Fabius JM; Soucheray M; Polacco BJ; Ak B; Marin A; Evans MJ; Swaney DL; Gonzalez-Reiche AS; Sordillo EM; van Bakel H; Simon V; Zuliani-Alvarez L; Fontoura BMA; Rosenberg BR; Krogan NJ; Martinez-Sobrido L; García-Sastre A; Miorin L
    Cell Host Microbe; 2023 Oct; 31(10):1668-1684.e12. PubMed ID: 37738983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection.
    Li M; Ayyanathan K; Dittmar M; Miller J; Tapescu I; Lee JS; McGrath ME; Xue Y; Vashee S; Schultz DC; Frieman MB; Cherry S
    mBio; 2023 Aug; 14(4):e0119423. PubMed ID: 37377442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolutionary and Phylogenetic Dynamics of SARS-CoV-2 Variants: A Genetic Comparative Study of Taiyuan and Wuhan Cities of China.
    Hussain B; Wu C
    Viruses; 2024 Jun; 16(6):. PubMed ID: 38932199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.
    Lista MJ; Winstone H; Wilson HD; Dyer A; Pickering S; Galao RP; De Lorenzo G; Cowton VM; Furnon W; Suarez N; Orton R; Palmarini M; Patel AH; Snell L; Nebbia G; Swanson C; Neil SJD
    J Virol; 2022 Dec; 96(23):e0125022. PubMed ID: 36350154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice.
    Ogger PP; Martín MG; Jang S; Zhou J; Brown J; Sukhova K; Furnon W; Patel AH; Cowton V; Palmarini M; Barclay WS; Johansson C
    Front Immunol; 2024; 15():1383612. PubMed ID: 38742107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment.
    Kumar S; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Oct; 94(10):4780-4791. PubMed ID: 35680610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
    Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
    Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 variants Alpha, Beta, Delta and Omicron show a slower host cell interferon response compared to an early pandemic variant.
    Laine L; Skön M; Väisänen E; Julkunen I; Österlund P
    Front Immunol; 2022; 13():1016108. PubMed ID: 36248817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BA.1, BA.2 and BA.2.75 variants show comparable replication kinetics, reduced impact on epithelial barrier and elicit cross-neutralizing antibodies.
    Singh J; Anantharaj A; Panwar A; Rani C; Bhardwaj M; Kumar P; Chattopadhyay P; Devi P; Maurya R; Mishra P; Pandey AK; Pandey R; Medigeshi GR
    PLoS Pathog; 2023 Feb; 19(2):e1011196. PubMed ID: 36827451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.
    Kehrer T; Cupic A; Ye C; Yildiz S; Bouhhadou M; Crossland NA; Barrall E; Cohen P; Tseng A; Çağatay T; Rathnasinghe R; Flores D; Jangra S; Alam F; Mena N; Aslam S; Saqi A; Marin A; Rutkowska M; Ummadi MR; Pisanelli G; Richardson RB; Veit EC; Fabius JM; Soucheray M; Polacco BJ; Evans MJ; Swaney DL; Gonzalez-Reiche AS; Sordillo EM; van Bakel H; Simon V; Zuliani-Alvarez L; Fontoura BMA; Rosenberg BR; Krogan NJ; Martinez-Sobrido L; García-Sastre A; Miorin L
    bioRxiv; 2022 Nov; ():. PubMed ID: 36299428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern.
    Aggarwal A; Akerman A; Milogiannakis V; Silva MR; Walker G; Stella AO; Kindinger A; Angelovich T; Waring E; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Jean T; Foster CSP; Christ D; Hoppe AC; Munier ML; Darley D; Churchill M; Stark DJ; Matthews G; Rawlinson WD; Kelleher AD; Turville SG
    EBioMedicine; 2022 Oct; 84():104270. PubMed ID: 36130476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Landscape of T cell epitopes displays hot mutations of SARS-CoV-2 variant spikes evading cellular immunity.
    Gan M; Cao J; Zhang Y; Fu H; Lin X; Ouyang Q; Xu X; Yuan Y; Fan X
    J Med Virol; 2024 Feb; 96(2):e29452. PubMed ID: 38314852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections.
    Medits I; Springer DN; Graninger M; Camp JV; Höltl E; Aberle SW; Traugott MT; Hoepler W; Deutsch J; Lammel O; Borsodi C; Puchhammer-Stöckl E; Zoufaly A; Weseslindtner L; Aberle JH; Stiasny K
    Front Immunol; 2022; 13():946318. PubMed ID: 35928813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrimination of SARS-CoV-2 omicron variant and its lineages by rapid detection of immune-escape mutations in spike protein RBD using asymmetric PCR-based melting curve analysis.
    Kong X; Gao P; Jiang Y; Lu L; Zhao M; Liu Y; Deng G; Zhu H; Cao Y; Ma L
    Virol J; 2023 Aug; 20(1):192. PubMed ID: 37626353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals.
    Emmelot ME; Vos M; Boer MC; Rots NY; van Els CACM; Kaaijk P
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular immune responses.
    Pérez P; Astorgano D; Albericio G; Flores S; Sánchez-Corzo C; Noriega MA; Sánchez-Cordón PJ; Labiod N; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J
    Front Immunol; 2024; 15():1420304. PubMed ID: 39267752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Rise and Fall of SARS-CoV-2 Variants and Ongoing Diversification of Omicron.
    Wiegand T; Nemudryi A; Nemudraia A; McVey A; Little A; Taylor DN; Walk ST; Wiedenheft B
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent NK-cell and neutralizing antibody responses against the Spike protein of Wuhan-Hu-1 and Omicron BA.1 SARS-CoV-2 variants in vaccinated experienced and vaccinated naïve individuals.
    Albert E; Fernández-Soto D; Giménez E; Casanovas JM; Zulaica J; Álvarez-Rodríguez B; Rusu L; Geller R; Reyburn HT; Navarro D
    J Med Virol; 2023 Jul; 95(7):e28900. PubMed ID: 37403730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies.
    Chatterjee S; Bhattacharya M; Nag S; Dhama K; Chakraborty C
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.